U.S. Markets closed

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CORT, TYME, TAP and UMC

NEW YORK, March 18, 2019 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.        


Corcept Therapeutics Incorporated (CORT)
Class Period: August 2, 2017 to February 5, 2019
Lead Plaintiff Deadline: May 13, 2019

Throughout the class period, Corcept Therapeutics Incorporated allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) the Company had improperly paid doctors to promote its drug Korlym; (2) the Company aggressively promoted Korlym for off-label uses; (3) the Company’s sole specialty pharmacy was a related party; (4) the Company artificially inflated its revenue and sales using illicit sales practices through a related party; (5) such practices are reasonably likely to lead to regulatory scrutiny; and (6) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Get additional information about the CORT lawsuit: http://www.kleinstocklaw.com/pslra-1/corcept-therapeutics-incorporated-loss-submission-form?wire=3

Tyme Technologies, Inc. (TYME)
Class Period: March 14, 2018 to January 18, 2019
Lead Plaintiff Deadline: March 29, 2019

The lawsuit alleges that throughout the class period, Tyme Technologies, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) Tyme had not adequately designed the Phase II Study to present reliable results on the efficacy of SM-88 on pancreatic cancer; (ii) Tyme had failed to include an appropriate control group in its open-label Phase II clinical trial for SM-88; (iii) the omission of an appropriate control group distorted the reliability of data showing the efficacy of SM-88 in the Phase II Study; and (iv) as a result, Tyme’s public statements were materially false and misleading at all relevant times.

Get additional information about the TYME lawsuit: http://www.kleinstocklaw.com/pslra-1/tyme-technologies-inc-loss-submission-form?wire=3

Molson Coors Brewing Company (TAP)
Class Period: February 14, 2017 to February 12, 2019
Lead Plaintiff Deadline: April 16, 2019

The complaint alleges Molson Coors Brewing Company made materially false and/or misleading statements and/or failed to disclose that: (1) Molson Coors failed to properly reconcile the outside basis deferred income tax liability for Molson Coors’ investment in its MillerCoors, LLC partnership; (2) consequently, Molson Coors misreported net income in its consolidated financial statements for the fiscal years ending December 31, 2016 and December 31, 2017, resulting in an overall downward revision to net income; (3) Molson Coors lacked adequate internal controls over financial reporting; and (4) as a result, defendants’ statements about Molson Coors’ business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Get additional information about the TAP lawsuit: http://www.kleinstocklaw.com/pslra-1/molson-coors-brewing-company-loss-submission-form?wire=3

United Microelectronics Corporation (UMC)
Class Period: October 28, 2015 to November 1, 2018
Lead Plaintiff Deadline: May 13, 2019

The complaint alleges that throughout the class period United Microelectronics Corporation made materially false and/or misleading statements and/or failed to disclose that: (i) UMC conspired with Fujian to steal trade secrets from Micron relating to its research and development of Dynamic Random-Access Memory ("DRAM"); (ii) UMC hired former Micron employees for the purpose of stealing such information from Micron; (iii) the foregoing conduct placed UMC and certain of its employees at an increased risk of criminal and regulatory investigation by the U.S. government; and (iv) as a result, UMC’s public statements were materially false and misleading at all relevant times.

Get additional information about the UMC lawsuit: http://www.kleinstocklaw.com/pslra-1/united-microelectronics-corporation-loss-submission-form?wire=3

 
Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. There is no cost or obligation to you. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com